Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Muscle-Invasive Bladder Cancer”

448 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 448 results

Not applicableStudy completedNCT06235853
What this trial is testing

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerCystoscopyRecurrence+3 more
Wroclaw Medical University 240
Testing effectiveness (Phase 2)Looking for participantsNCT06800963
What this trial is testing

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Who this might be right for
NMIBC
ImmunityBio, Inc. 40
Large-scale testing (Phase 3)Study completedNCT00445601
What this trial is testing

S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 406
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268339
What this trial is testing

A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.

Who this might be right for
High-Risk Non-Muscle Invasive Bladder Cancer
The Christie NHS Foundation Trust 328
Not applicableStudy completedNCT06818799
What this trial is testing

Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Transitional Cell Carcinoma
Helwan University 50
Not applicableEnded earlyNCT06026332
What this trial is testing

ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

Who this might be right for
Bladder Cancer
Ferring Pharmaceuticals 202
Testing effectiveness (Phase 2)Looking for participantsNCT05024734
What this trial is testing

Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids

Who this might be right for
Bladder CancerNon-muscle Invasive
Roland Seiler-Blarer 34
Not applicableNot Yet RecruitingNCT06678633
What this trial is testing

T-Control® Safety for Cytostatics Management

Who this might be right for
Non-muscle-invasive Bladder Cancer
Rethink Medical SL 16
Early research (Phase 1)Looking for participantsNCT06632964
What this trial is testing

A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
The Affiliated Hospital of Xuzhou Medical University 16
Large-scale testing (Phase 3)Active Not RecruitingNCT03711032
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

Who this might be right for
High-risk Non-muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 1,397
Testing effectiveness (Phase 2)Study completedNCT00318643
What this trial is testing

Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
Halozyme Therapeutics 27
Testing effectiveness (Phase 2)WithdrawnNCT05120622
What this trial is testing

Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerHigh-Risk CancerTremelimumab+2 more
University of British Columbia
Not applicableEnded earlyNCT02202044
What this trial is testing

Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection

Who this might be right for
Bladder Carcinoma
University of Colorado, Denver 13
Testing effectiveness (Phase 2)Looking for participantsNCT06663137
What this trial is testing

Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC

Who this might be right for
Non Muscle Invasive Bladder Cancer
Relmada Therapeutics, Inc. 70
Large-scale testing (Phase 3)Active Not RecruitingNCT02106572
What this trial is testing

Therapeutic Instillation of Mistletoe

Who this might be right for
Superficial Bladder Cancer
Abnoba Gmbh 548
Large-scale testing (Phase 3)UnknownNCT01082510
What this trial is testing

Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study)

Who this might be right for
Bladder Cancer
Urological Oncology Council of Northern Tokyo 288
Not applicableUnknownNCT05508568
What this trial is testing

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Arquer Diagnostics Ltd 650
Not applicableStudy completedNCT02381912
What this trial is testing

Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer

Who this might be right for
Urinary Bladder NeoplasmsSexual Dysfunction, PhysiologicalSexual Dysfunctions, Psychological+2 more
Herlev Hospital 210
Testing effectiveness (Phase 2)UnknownNCT04671407
What this trial is testing

The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer

Who this might be right for
TCC
Kaplan Medical Center 150
Load More Results